Annual EBITDA
-$215.24M$9.56M-4.65%
Summary
- Current Value
- As of today, DAWN annual EBITDA is -$215.24M, down -4.65% on
- Historical Performance
- DAWN annual EBITDA is down -196.70% over the past 3 years, and down -1343.89% over the past 5 years
- All-Time High Comparison
- DAWN annual EBITDA is currently -1479.52% below its historical high of -$13.63M set on
- 3-Year Low Comparison
- DAWN annual EBITDA is at its 3-year low
- Sector Comparison
- DAWN annual EBITDA is higher than 6.69% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$215.24M | -4.7% | -196.7% | -1343.9% | -1343.9% | |
| Quarterly EBITDA | -$23.31M | -176.7% | +41.0% | -563.2% | -283.6% | |
| TTM EBITDA | -$162.07M | +22.9% | -28.8% | -1077.5% | -1376.3% | |
| Price | $9.61 | -22.5% | -55.0% | – | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $131.16M | +100.0% | +100.0% | +100.0% | +100.0% | |
| Annual EPS | -$1.02 | +56.8% | +62.8% | -402.1% | -402.1% | |
| -$217.27M | -5.4% | -198.7% | -1357.5% | -1357.5% | ||
| Annual Net Income | -$95.50M | +49.5% | -31.3% | -462.3% | -462.3% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$146.38M | N/A | -47.0% |
| 5Y | -$13.63M | N/A | -1479.5% |
| All | -$13.63M | -1479.5% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$215.24M | at low | |
| 5Y | -$215.24M | at low | |
| All | -$215.24M | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$215.24M | -4.6% | |
| -$205.68M | -40.5% | |
| -$146.38M | -101.8% |
| Year | Value | Change |
|---|---|---|
| -$72.54M | -432.4% | |
| -$13.63M | +8.6% | |
| -$14.91M | - |
FAQ
What is the current annual EBITDA of DAWN?
As of today, DAWN annual EBITDA is -$215.24M
What is 1-year change in DAWN annual EBITDA?
DAWN annual EBITDA is down -4.65% year-over-year
What is 3-year change in DAWN annual EBITDA?
DAWN annual EBITDA is down -196.70% over the past 3 years
How far is DAWN annual EBITDA from its all-time high?
DAWN annual EBITDA is currently -1479.52% below its historical high of -$13.63M set on December 31, 2020
How does DAWN annual EBITDA rank versus sector peers?
DAWN annual EBITDA is higher than 6.69% of companies in Healthcare sector
When is DAWN next annual earnings release?
The next annual earnings release for DAWN is on
Quarterly EBITDA
-$23.31M$10.70M+31.46%
Summary
- Current Value
- As of today, DAWN quarterly EBITDA is -$23.31M, up +31.46% on
- Historical Performance
- DAWN quarterly EBITDA is down -176.73% year-over-year, and up +41.03% over the past 3 years
- All-Time High Comparison
- DAWN quarterly EBITDA is currently -126.83% below its historical high of $86.88M set on
- 3-Year Low Comparison
- DAWN quarterly EBITDA is +79.62% above its 3-year low of -$114.40M reached on
- Sector Comparison
- DAWN quarterly EBITDA is higher than 18.14% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$23.31M | +31.5% | -176.7% | +41.0% | -563.2% | |
| Annual EBITDA | -$215.24M | – | -4.7% | -196.7% | -1343.9% | |
| TTM EBITDA | -$162.07M | -49.5% | +22.9% | -28.8% | -1077.5% | |
| Price | $9.61 | +29.7% | -22.5% | -55.0% | – | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $39.80M | +17.4% | -57.6% | +100.0% | +100.0% | |
| Quarterly EPS | -$0.19 | +35.1% | -149.9% | +64.2% | -318.4% | |
| -$24.25M | +30.7% | -181.8% | +38.9% | -581.0% | ||
| Quarterly Net Income | -$19.73M | +34.9% | -153.3% | +47.8% | -413.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$23.31M | at high | |
| 3Y | $30.38M | -176.7% | |
| 5Y | $30.38M | -176.7% | |
| All | $86.88M | -126.8% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$64.57M | N/A | +63.9% |
| 3Y | -$114.40M | +79.6% | |
| 5Y | -$114.40M | +79.6% | |
| All | -$114.40M | +79.6% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of DAWN?
As of today, DAWN quarterly EBITDA is -$23.31M
What is DAWN quarterly EBITDA most recent change?
DAWN quarterly EBITDA was up +31.46% on September 30, 2025
What is 1-year change in DAWN quarterly EBITDA?
DAWN quarterly EBITDA is down -176.73% year-over-year
How far is DAWN quarterly EBITDA from its all-time high?
DAWN quarterly EBITDA is currently -126.83% below its historical high of $86.88M set on March 1, 2019
How does DAWN quarterly EBITDA rank versus sector peers?
DAWN quarterly EBITDA is higher than 18.14% of companies in Healthcare sector
When is DAWN next earnings release?
The next earnings release for DAWN is on
TTM EBITDA
-$162.07M$53.69M-49.55%
Summary
- Current Value
- As of today, DAWN TTM EBITDA is -$162.07M, down -49.55% on
- Historical Performance
- DAWN TTM EBITDA is up +22.85% year-over-year, and down -28.84% over the past 3 years
- All-Time High Comparison
- DAWN TTM EBITDA is currently -190.19% below its historical high of $179.70M set on
- 3-Year Low Comparison
- DAWN TTM EBITDA is +44.46% above its 3-year low of -$291.80M reached on
- Sector Comparison
- DAWN TTM EBITDA is higher than 9.66% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$162.07M | -49.5% | +22.9% | -28.8% | -1077.5% | |
| Annual EBITDA | -$215.24M | – | -4.7% | -196.7% | -1343.9% | |
| Quarterly EBITDA | -$23.31M | +31.5% | -176.7% | +41.0% | -563.2% | |
| Price | $9.61 | +29.7% | -22.5% | -55.0% | – | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $133.67M | -28.8% | +31.1% | +100.0% | -63.5% | |
| TTM EPS | -$1.49 | -62.8% | -46.6% | +24.3% | -10000.0% | |
| -$165.62M | -48.2% | +21.7% | -31.3% | -2456.2% | ||
| TTM Net Income | -$151.76M | -59.8% | -80.0% | -22.4% | -10000.0% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$108.37M | -49.5% | |
| 3Y | -$108.37M | -49.5% | |
| 5Y | -$13.63M | N/A | -1089.2% |
| All | $179.70M | -190.2% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$215.24M | N/A | +24.7% |
| 3Y | -$291.80M | +44.5% | |
| 5Y | -$291.80M | +44.5% | |
| All | -$291.80M | +44.5% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of DAWN?
As of today, DAWN TTM EBITDA is -$162.07M
What is DAWN TTM EBITDA most recent change?
DAWN TTM EBITDA was down -49.55% on September 30, 2025
What is 1-year change in DAWN TTM EBITDA?
DAWN TTM EBITDA is up +22.85% year-over-year
How far is DAWN TTM EBITDA from its all-time high?
DAWN TTM EBITDA is currently -190.19% below its historical high of $179.70M set on September 1, 2019
How does DAWN TTM EBITDA rank versus sector peers?
DAWN TTM EBITDA is higher than 9.66% of companies in Healthcare sector
When is DAWN next earnings release?
The next earnings release for DAWN is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- DAWN Official Website dayonebio.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1845337/000119312525264649/0001193125-25-264649-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1845337/000095017025026654/0000950170-25-026654-index.htm
- DAWN Profile on Yahoo Finance finance.yahoo.com/quote/DAWN
- DAWN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dawn